More and more businesses are transitioning to a digital platform, using the power of technology to improve the products and services offered and delivered to consumers. Most industries impacted most prevalently by the tech boom have included retail businesses, but the healthcare sector is beginning its catch-up. The most recent shift toward a more digitally focused consumer experience is pharmacy operations. Many patients are demanding faster, more efficient tracking and delivering of their prescription medications from pharmacies without a physical location. While some organisations have seen this transformation as an opportunity for improving patient care, others cite risks and challenges in creating a sustainable digital pharmacy experience for the majority of patients.
In the UK, online pharmacies are also known as distance selling pharmacies, and they have been in operation albeit on a small scale since 1999. As of 2015, just under 500 online pharmacies existing, most of which were connected to a physical location provider for ease of service. Most online pharmacies in the UK today create a more streamlined process for patients to receive prescription medications quickly. Doctors simply fill a prescription through the pharmacy platform, and patients have the opportunity to either pick it up at an actual location or have it delivered to their door. The idea behind digital platforms for prescriptions relies heavily on the retailer to consumer model like technology giant Amazon. Individuals want quick service from the comfort and convenience of their home, particularly those managing chronic conditions that hinder their ability to get out to a physical pharmacy location.
The most significant opportunity in online pharmacy providers is the improved efficiency in relaying prescription data to the patient, his or her GP, and the pharmacy. This type of system offers more transparency in medication management when it is
Regarded as one of the biggest Pharmaceutical breakthroughs of the 20th century, the introduction of the measles vaccine to the masses in the early 1960s brought the total count down by thousands per year, which later lead to the mass eradication of the dreaded disease in several parts of the world.
As of 2013, the number of measles cases in countries such as the UK and some other parts of Europe dropped to almost zero.
Perhaps the most noteworthy success story of immunization was the total eradication of polio in India back in 2014.
A few decades ago, however, a former British medical researcher, Andrew Wakefield, sparked off a notion that some vaccines were directly linked to autism in children. He even got a journal published on the same without valid peer review. This caused widespread fear and hysteria among people across Europe and the US.
But the day was saved after scientists pointed out that Wakefield’s journal and research were fraudulent, and proved it by successfully demonstrating, through experiments, that vaccines had no relation to autism.
But the conspiracy theory refused to die out, ultimately leading to a landfall in immunization rates, especially in 2014 and 2016.
As per experts, populist politics in some First World nations lead to an increased strengthening of the anti-vaccination and anti-science lobby.
Several experienced scientists and medical professionals expressed fears that these groups were jeopardizing public health. And to confirm their fears, Measles, which was declining and dormant for quite a while, is threatening a potential outbreak in the UK and the US – two nations with the strongest opponents to vaccination.
To allay these dangerous misconceptions, we will elicit answers to questions people generally have about vaccines, from the most esteemed public health organizations across the world.